• Company
• MSD received administrative disposition for packaging
• by Whang, hyung-woo Jan 12, 2021 06:19am

• Policy
• Breaking down MOHW 2021 action plan for NHI Master Plan
• by Kim, Jung-Ju Jan 12, 2021 06:19am

• Company
• HK inno.N wins big in huge shift of global vaccine licenses
• by Kim, Jin-Gu Jan 11, 2021 06:11am

• Policy
• 22 generics for Atozet by Chong Kun Dang were approved
• by Lee, Tak-Sun Jan 11, 2021 06:10am

• Policy
• Plasma treatment was completed in Phase II clinical trial
• by Lee, Tak-Sun Jan 11, 2021 06:10am

• Policy
• Adenovirus for AZ vaccine, Sinopharm uses inactivated virus
• by Lee, Tak-Sun Jan 11, 2021 06:10am

• Company
• Allergan Korea names Kim Sook-hyun as new CEO
• by Jan 11, 2021 06:10am

• Opinion
• [Reproter's View] Have you forgotten what the MFDS does?
• by Lee, Tak-Sun Jan 8, 2021 06:21am

• Company
• 51 Jardiance patent-challenging generics released in 4 years
• by Kim, Jin-Gu Jan 8, 2021 06:20am

• Company
• Korean-made novel drug Kanarb keeps on evolving
• by Kim, Jin-Gu Jan 8, 2021 06:20am